| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,291 | 25,042 | 25,775 | 26,502 | | Cost of Revenue | 6,787 | 7,271 | 5,952 | 7,222 | | | Gross Profit | 18,504 | 17,771 | 19,823 | 19,280 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 589 | 623 | 531 | 684 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,921 | 6,335 | 5,944 | 6,160 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,994 | 10,813 | 13,348 | 12,436 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,557 | 3,557 | (2,816) | 492 | | Earnings Before Interest And Taxes | 16,387 | 14,445 | 10,621 | 50,651 | | Interest Expense | 5,382 | 7,256 | 4,987 | 5,187 | | Income Before Tax | 11,005 | 7,189 | 5,634 | 45,464 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (18,083) |
-
|
-
| (21,185) | | | | Net Income From Continuing Ops | (6,841) | 7,189 | 5,634 | 5,258 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,841) | 7,189 | 5,634 | 5,258 | | Preferred Stock And Other Adjustments | 9,607 | (5,405) | (4,202) |
-
| | | Net Income Applicable To Common Shares | $2,766 | $1,784 | $1,432 | $5,258 |
|
0.51% Nasdaq 
Income Statement
